PCa Risk Higher In Men with Heart Disease

Share this article:

Coronary artery disease (CAD) was associated with a 35% increased risk of a prostate cancer (PCa) diagnosis among the 6,390 men taking part in the REDUCE trial, which evaluated whether dutasteride reduced PCa risk. Overall, 547 enrollees (8.6%) had a history of CAD.

Compared with men who had no heart disease, those with CAD were 24% more likely to be diagnosed with PCa two years into the REDUCE trial and 74% more likely four years into the study, Stephen J. Freedland, MD, and colleagues reported in Cancer Epidemiology, Biomarkers & Prevention.

Share this article:
You must be a registered member of RUN to post a comment.

Next Article in News in Brief

More in News in Brief

AVF Placement Less Likely in Metropolitan Areas

Rates of AVF placement in patients approaching HD in the US are significantly lower in metropolitan areas.

ESA Resistance Found To Increase Mortality

Greater resistance to ESA is associated with an increased risk of death among patients on chronic HD.

Overactive Bladder Found to Raise Nocturia Risk

Overactive Bladder Found to Raise Nocturia Risk

In a study, severe nocturia predicted increased mortality risk.